spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 3


Fig. 3. LY294002 induced-phenotypic reversion of malignant cells is accompanied with the re-establishment of basal polarity and higher order nuclear structure. Malignant T4-2 cells were treated either with the reverting agent LY294002 or vehicle DMSO for 10 days in 3D culture in the presence of MatrigelTM and labeled for differentiation markers collagen IV, {alpha}6-integrin, mucin-1 and Ki67, and nuclear proteins H4K20m, NuMA and SC35. (A) Immunostaining for basal polarity markers collagen IV (green) and {alpha}6-integrin (green), apical polarity marker mucin-1 (red), and proliferation marker Ki67 (green) in malignant (T4-2) cells (small tumor nodules are shown) and reverted (RT4-2) cells. Nuclei are counterstained with DAPI (blue). (B) Organization of heterochromatin marker H4K20m (red), coiled-coil protein NuMA (green; arrowheads indicate the presence of enlarged foci in mid-nucleus) and splicing factor speckle marker SC35 (green) in the nuclei of malignant (T4-2) and reverted (RT4-2) cells. The dotted line delineates the cell nucleus. Bars, 5 µm.





Right arrow Return to article